| Composition | Telmisartan 40mg Rosuvastatin 10mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×10 |
| Packing | Alu-Alu |
TELECIA RS 40/10 is a combination therapy formulated with Telmisartan (40 mg) and Rosuvastatin (10 mg) to manage hypertension and dyslipidemia simultaneously. This dual-action medication is designed for patients who require blood pressure control along with cholesterol management to reduce the risk of cardiovascular complications.
By combining an angiotensin II receptor blocker (Telmisartan) with a HMG-CoA reductase inhibitor (Rosuvastatin), TELECIA RS 40/10 provides comprehensive cardiovascular protection in a single convenient tablet.
Each tablet contains:
Telmisartan 40 mg – An angiotensin II receptor blocker (ARB) that relaxes blood vessels, reducing blood pressure and improving heart function.
Rosuvastatin 10 mg – A statin that inhibits HMG-CoA reductase, lowering LDL cholesterol, total cholesterol, and triglycerides while increasing HDL cholesterol.
Tablet
Antihypertensive & Lipid-Lowering Agent
TELECIA RS 40/10 Tablets are indicated for:
Management of essential hypertension
Control of hypercholesterolemia and mixed dyslipidemia
Reducing cardiovascular risk in patients with hypertension and elevated cholesterol
Patients requiring combination therapy for blood pressure and lipid control
Telmisartan blocks angiotensin II receptors, preventing vasoconstriction, reducing peripheral resistance, and lowering blood pressure.
Rosuvastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver, lowering LDL and triglycerides, and stabilizing atherosclerotic plaques.
The combination addresses two major cardiovascular risk factors—hypertension and high cholesterol—effectively and conveniently.
Recommended Dose: As prescribed by the physician, usually once daily.
Route: Oral
Duration: Long-term therapy as advised by a healthcare provider.
Note: Regular monitoring of blood pressure, lipid profile, and liver function is recommended during therapy.
Controls high blood pressure and reduces cardiovascular strain
Lowers LDL cholesterol and triglycerides, while raising HDL
Reduces risk of heart attack, stroke, and atherosclerosis
Provides dual cardiovascular protection in a single tablet
Convenient once-daily dosing enhances patient compliance
TELECIA RS 40/10 is generally well tolerated. Possible side effects may include:
Dizziness or headache
Mild gastrointestinal disturbances
Muscle pain or weakness (rare, associated with statins)
Hypotension in sensitive patients
Patients should consult their physician if side effects persist.
Monitor kidney and liver function during prolonged therapy
Not recommended in pregnancy or lactation
Use with caution in patients with renal impairment or history of liver disease
Avoid abrupt discontinuation without medical advice
Inform the doctor about other medications to prevent drug interactions
Store below 25°C, in a dry place away from direct sunlight. Keep out of reach of children.
Brand Name: TELECIA RS 40/10
Composition: Telmisartan 40 mg + Rosuvastatin 10 mg
Dosage Form: Tablet
Therapeutic Class: Antihypertensive & Lipid-Lowering Agent
Manufacturer: [Insert Company Name]
Packaging: [Example: 10×10 Tablets / Strip]
Combines blood pressure control and cholesterol management in a single tablet
Reduces cardiovascular risk factors efficiently
Convenient once-daily dose improves adherence
Manufactured under strict GMP quality standards
Ideal for patients with comorbid hypertension and hyperlipidemia
TELECIA RS 40/10 (Telmisartan 40 mg + Rosuvastatin 10 mg) is a dual-action cardiovascular therapy that effectively manages hypertension and dyslipidemia. By controlling blood pressure and cholesterol simultaneously, it helps reduce the risk of heart disease, stroke, and other cardiovascular complications, providing comprehensive protection for a healthier heart.
